Acro Biomedical (ACBM) Non-Current Debt (2021 - 2022)
Acro Biomedical (ACBM) recorded quarterly Non-Current Debt of $78826.0 in Q4 2022, up 280.05% quarter-over-quarter from $20741.0 in Q4 2021, and up 280.05% on a YoY basis from $20741.0 in Q4 2021.
Acro Biomedical (ACBM) Non-Current Debt (2021 - 2022) Analysis & Trends
Acro Biomedical's Non-Current Debt history runs 2 years deep, the most recent figure standing at $78826.0 for Q4 2022.
- In Q4 2022, Non-Current Debt rose 280.05% year-over-year to $78826.0; the TTM figure through Dec 2022 stood at $78826.0 (up 280.05% YoY), while the FY2022 annual figure was $78826.0, up 280.05% from the prior year.
- Non-Current Debt was $78826.0 for Q4 2022 at Acro Biomedical, up from $20741.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $78826.0 in Q4 2022 to a low of $20741.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | 542,975.00 |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 78,826.00 |
| Dec 31, 2022 | 78,826.00 |
| Dec 31, 2021 | 20,741.00 |
| Dec 31, 2021 | 20,741.00 |